AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $56,975 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2010 | $23,490 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $8,801 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2011 | $2,572 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2011 | $3,743 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2011 | $6,773 | | tax credit/rebate |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2011 | $8,686 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2011 | $9,731 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2011 | $20,940 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2011 | $21,304 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2011 | $21,743 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2011 | $31,277 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2011 | $37,523 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2011 | $62,613 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $78,340 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $96,902 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2011 | $123,488 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $158,503 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2011 | $161,293 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2011 | $189,498 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2011 | $220,883 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $318,349 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $444,809 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2011 | $501,793 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2011 | $550,523 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2011 | $4,039,279 | | tax credit/rebate |
Abbott Bioresearch Center, inc. | Abbott Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | Massachusetts | state | 2006 | undisclosed | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
EMD Serono | Merck KGaA (EMD) | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
Epichem, Inc. | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
IDEXX Veterinary Services | IDEXX Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
PAREXEL International | Parexel International | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
PAREXEL International Corp. | Parexel International | Massachusetts | state | 1998 | undisclosed | | tax credit/rebate |
Parexel International, LLC | Parexel International | Massachusetts | state | 2011 | $29,879 | | tax credit/rebate |
Serono Labs | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
Shire Human Genetics Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2005 | undisclosed | | tax credit/rebate |
Andrx Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | Florida | state | 2003 | undisclosed | | tax credit/rebate |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 1998 | $815,500 | | tax credit/rebate |
Andrx Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2004 | $525,000 | | tax credit/rebate |
Bausch & Lomb Incorporated - Clearwater Facility | Bausch Health | Florida | state | 2005 | $135,000 | | tax credit/rebate |
Genzyme Corporation | Sanofi | Florida | state | 2010 | $524,000 | | tax credit/rebate |
Schering Corporation | Merck | Florida | state | 2007 | $84,000 | | tax credit/rebate |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Florida | state | 2000 | $312,000 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2012 | $10,263,039 | | tax credit/rebate |
Janssen Research & Development, LLC ( f/k/a J&J Pharmaceutical Research & Development, LLC) | Johnson & Johnson | Pennsylvania | state | 2012 | $5,461,142 | | tax credit/rebate |
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2012 | $4,247,696 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Pennsylvania | state | 2012 | $3,552,766 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2012 | $999,077 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2012 | $454,512 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2012 | $342,911 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2012 | $297,513 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2012 | $162,846 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2012 | $160,814 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2012 | $98,234 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2012 | $28,896 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2012 | $24,402 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $12,593 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $2,611 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $3,872 | | tax credit/rebate |
AXIS SHIELD DIAGNOSTICS LIMITED | Abbott Laboratories | Washington | state | 2011 | $4,930 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $12,368 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $18,072 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2011 | $28,045 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $60,285 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $83,248 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $181,239 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $207,108 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $11,724 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $19,669 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $33,727 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2011 | $42,682 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $51,253 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $91,754 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $106,749 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $143,394 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2011 | $3,568,422 | | tax credit/rebate |
Alexion Pharmaceuticals | AstraZeneca | Connecticut | state | 2012 | $51,000,000 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $253,000 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $22,005 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2004 | $581,065 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $481,822 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2005 | $581,065 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $375,100 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2006 | $397,686 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2006 | $72,042 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2006 | $485,991 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2006 | $68,653 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $380,245 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2007 | $116,504 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2007 | $1,375 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2007 | $3,626,627 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $518,618 | | tax credit/rebate |